| High-dose vitamin C for cancer therapy A Mussa, RA Mohd Idris, N Ahmed, S Ahmad, AH Murtadha, ... Pharmaceuticals 15 (6), 711, 2022 | 41 | 2022 |
| The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer A Mussa, HA Afolabi, NH Syed, M Talib, AH Murtadha, K Hajissa, ... Biomedicines 11 (4), 1060, 2023 | 7 | 2023 |
| Prognostic prospect of soluble programmed cell death ligand-1 in cancer management NA Khairil Anwar, MN Mohd Nazri, AH Murtadha, ER Mohd Adzemi, ... Acta biochimica et biophysica Sinica 53 (8), 961-978, 2021 | 6 | 2021 |
| nNav1. 5 expression is associated with glutamate level in breast cancer cells II Azahar, NA Sharudin, AHM Noor Din, AT Che Has, SN Mohd Nafi, ... Biological Research 55 (1), 18, 2022 | 4 | 2022 |
| Influence of nNav1. 5 on MHC class I expression in breast cancer AH Murtadha, IIM Azahar, NA Sharudin, ATC Has, NF Mokhtar Journal of Biosciences 46, 1-12, 2021 | 4 | 2021 |
| Invasion and metastasis suppression by anti-neonatal Nav1. 5 antibodies in breast cancer NA Sharudin, AHMN Din, II Azahar, MM Azlan, NS Yaacob, ME Sarmiento, ... Asian Pacific journal of cancer prevention: APJCP 23 (9), 2953, 2022 | 3 | 2022 |
| Upregulation of MHC I Antigen Processing Machinery Gene Expression in Breast Cancer Cells by Trichostatin A AH Murtadha, NA Sharudin, IIM Azahar, ATC Has, NF Mokhtar Molecular Biology 57 (6), 1212-1227, 2023 | | 2023 |
| Development of MDA-MB-231-3D-Spheroid as a reliable model for studying Nav1. 5 and nNav1. 5-mediated breast cancer metastasis AH Murtadha, NF Mokhtar Annals of Oncology 30, ix18, 2019 | | 2019 |
| Development and characterisation of mouse monoclonal antibody against ‘neonatal’Nav1. 5 NA Sharudina, NAK Anwara, MNM Nazria, A Hafiz, FHH Murtadhaa, ... | | |
Noor Fatmawati MokhtarLecturer/Researcher of Cancer Research, Institute for Research in Molecular Medicine (INFORMMVerified email at usm.my
